‘I’m still in a bit of shock’: YouTuber Ninja Diagnosed with Melanoma, Encourages Skin Checks

Gamer Tyler Blevins, known by his online alias Ninja, revealed he has been diagnosed with early-stage melanoma skin cancer. He credits his annual skin check with allowing doctors to identify a suspicious mole. The 32-year-old professional gamer wrote on Twitter: “Alright, I’m still in a bit of shock but want to keep you all updated. … Read more

Sarah Ferguson Admits ‘Shock’ Yet Remains Positive Despite Skin Cancer Battle

Sarah Ferguson is not letting her skin cancer diagnosis get her down as she shares that she remains determined to raise awareness about the disease through her personal experience. The Duchess of York talked about her battle with breast cancer last year, and her subsequent melanoma diagnosis in a recent Instagram post where she added … Read more

Immunotherapy Eliminates Senescent Cells, Enhancing Chemotherapy Efficiency |

BARCELONA: Apart from eliminating a significant portion of the tumour cells, cancer therapies such as chemotherapy also produce senescent tumour cells, which are also referred to as “zombi cells.” Senescent cells do not proliferate, but regrettably, they create an atmosphere that is conducive to the growth of tumour cells that may have evaded the effects … Read more

Sarah Ferguson Hit With Distressing Health News After Breast Cancer Battle

Sarah Ferguson is facing another health hurdle following reports that she has been diagnosed with skin cancer. She was previously diagnosed with an early form of breast cancer last June and underwent single mastectomy. In a statement published by People, a representative for the 64-year-old shared that she “has now been diagnosed with malignant melanoma”. … Read more

Moderna, Merck Drugs Combined Shown Effective Against Melanoma

U.S. pharmaceutical companies Moderna and Merck say a clinical trial for an experimental Moderna mRNA vaccine used in combination with the Merck cancer therapy drug Keytruda reduced the chance of recurrence or death from melanoma by nearly 50%. In a release from Moderna on Thursday, the company said the trial included 157 patients with high-risk … Read more